Header Logo

Connection

David Smelson to Adult

Back to Details
This is a "connection" page, showing publications David Smelson has written about Adult.
David Smelson
Connection Strength
1.473
Adult
  1. Bruzios K, Shaffer PM, Blonigen DM, Cucciare MA, Andre M, Byrne T, Smith J, Smelson D. Intervention for Justice-Involved Homeless Veterans With Co-Occurring Substance Use and Mental Health Disorders: Protocol for a Randomized Controlled Hybrid Effectiveness-Implementation Trial. JMIR Res Protoc. 2025 Jul 18; 14:e70750.
    View in: PubMed
    Score: 0.072
  2. Helm A, Shaffer P, Gonzalez G, Li W, Olmstead T, Berlowitz D, Epstein E, Smelson D. Protocol of a randomized controlled trial examining psychosocial enhancement and standard medication treatment for co-occurring opioid use and mental health disorders: A half fractional factorial randomized controlled trial. Contemp Clin Trials. 2024 Oct; 145:107668.
    View in: PubMed
    Score: 0.068
  3. Helm AF, Andre MA, Shaffer PM, Bruzios KE, Marcus S, Harter J, Smelson D. Multicomponent Co-Occurring Disorders Treatment and Wraparound Services for Individuals Experiencing Chronic Homelessness. Community Ment Health J. 2024 Aug; 60(6):1203-1213.
    View in: PubMed
    Score: 0.066
  4. Gaba A, Helm A, Shaffer PM, Pridgen B, Drawbridge D, Smelson D. Community reentry: Racial/ethnic differences in unmet needs among adults with co-occurring opioid use and mental health disorder. Int J Law Psychiatry. 2023 Nov-Dec; 91:101924.
    View in: PubMed
    Score: 0.063
  5. Blonigen D, Hyde J, McInnes DK, Yoon J, Byrne T, Ngo T, Smelson D. Integrating data analytics, peer support, and whole health coaching to improve the health outcomes of homeless veterans: Study protocol for an effectiveness-implementation trial. Contemp Clin Trials. 2023 02; 125:107065.
    View in: PubMed
    Score: 0.060
  6. Gaba A, Shaffer PM, Andre M, Pinals DA, Drawbridge D, Smelson D. Racial and ethnic differences in behavioral health, criminal legal system involvement, and service needs among mental health court participants: Implications for service delivery. Psychol Serv. 2022 Nov; 19(4):637-647.
    View in: PubMed
    Score: 0.058
  7. Blonigen DM, Cucciare MA, Byrne T, Shaffer PM, Giordano B, Smith JS, Timko C, Rosenthal J, Smelson D. A randomized controlled trial of moral reconation therapy to reduce risk for criminal recidivism among justice-involved adults in mental health residential treatment. J Consult Clin Psychol. 2022 May; 90(5):413-426.
    View in: PubMed
    Score: 0.057
  8. Pinals DA, Gaba A, Shaffer PM, Andre MA, Smelson DA. Risk-need-responsivity and its application in behavioral health settings: A feasibility study of a treatment planning support tool. Behav Sci Law. 2021 Feb; 39(1):44-64.
    View in: PubMed
    Score: 0.053
  9. Pinals DA, Gaba A, Clary KM, Barber J, Reiss J, Smelson D. Implementation of MISSION-Criminal Justice in a Treatment Court: Preliminary Outcomes Among Individuals With Co-occurring Disorders. Psychiatr Serv. 2019 11 01; 70(11):1044-1048.
    View in: PubMed
    Score: 0.048
  10. Corrigan PW, Qin S, Davidson L, Schomerus G, Shuman V, Smelson D. Public Perceptions of Recovery Prospects and Peer Style (Support and Confrontation) in Services for Serious Mental Illness Versus Substance Use Disorder. J Dual Diagn. 2019 Oct-Dec; 15(4):226-232.
    View in: PubMed
    Score: 0.048
  11. Corrigan PW, Qin S, Davidson L, Schomerus G, Shuman V, Smelson D. How does the public understand recovery from severe mental illness versus substance use disorder? Psychiatr Rehabil J. 2019 Dec; 42(4):341-349.
    View in: PubMed
    Score: 0.047
  12. Jasuja GK, Ameli O, Miller DR, Land T, Bernson D, Rose AJ, Berlowitz DR, Smelson DA. Overdose risk for veterans receiving opioids from multiple sources. Am J Manag Care. 2018 11; 24(11):536-540.
    View in: PubMed
    Score: 0.045
  13. Blonigen DM, Cucciare MA, Timko C, Smith JS, Harnish A, Kemp L, Rosenthal J, Smelson D. Study protocol: a hybrid effectiveness-implementation trial of Moral Reconation Therapy in the US Veterans Health Administration. BMC Health Serv Res. 2018 03 07; 18(1):164.
    View in: PubMed
    Score: 0.043
  14. Smelson D, Farquhar I, Fisher W, Pressman K, Pinals DA, Samek B, Duffy MK, Sawh L. Integrating a Co-occurring Disorders Intervention in Drug Courts: An Open Pilot Trial. Community Ment Health J. 2019 02; 55(2):222-231.
    View in: PubMed
    Score: 0.043
  15. Trojano ML, Christopher PP, Pinals DA, Harnish A, Smelson D. Perceptions of voluntary consent among jail diverted veterans with co-occurring disorders. Behav Sci Law. 2017 Sep; 35(5-6):408-417.
    View in: PubMed
    Score: 0.041
  16. Harnish A, Corrigan P, Byrne T, Pinals DA, Rodrigues S, Smelson D. Substance Use and Mental Health Stigma in Veterans With Co-Occurring Disorders. J Dual Diagn. 2016 Jul-Dec; 12(3-4):238-243.
    View in: PubMed
    Score: 0.039
  17. Smelson DA, Kline A, Kuhn J, Rodrigues S, O'Connor K, Fisher W, Sawh L, Kane V. A wraparound treatment engagement intervention for homeless veterans with co-occurring disorders. Psychol Serv. 2013 May; 10(2):161-7.
    View in: PubMed
    Score: 0.030
  18. Smelson D, Yu L, Buyske S, Gonzalez G, Tischfield J, Deutsch CK, Ziedonis D. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence. Am J Addict. 2012 Sep-Oct; 21(5):411-5.
    View in: PubMed
    Score: 0.030
  19. Smelson D, Chen KW, Ziedonis D, Andes K, Lennox A, Callahan L, Rodrigues S, Eisenberg D. A pilot study of Qigong for reducing cocaine craving early in recovery. J Altern Complement Med. 2013 Feb; 19(2):97-101.
    View in: PubMed
    Score: 0.029
  20. Smelson D, Kalman D, Losonczy MF, Kline A, Sambamoorthi U, Hill LS, Castles-Fonseca K, Ziedonis D. A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community Ment Health J. 2012 Apr; 48(2):127-32.
    View in: PubMed
    Score: 0.026
  21. Smelson DA, Ziedonis D, Williams J, Losonczy MF, Williams J, Steinberg ML, Kaune M. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clin Psychopharmacol. 2006 Feb; 26(1):9-12.
    View in: PubMed
    Score: 0.019
  22. Pivovarova E, Taxman FS, Boland AK, Andraka-Christou B, De La Cruz BA, Smelson D, Lemon SC, Friedmann PD. Medication for Opioid Use Disorders (MOUD) Providers' Experiences with Recovery Courts: Qualitative Study of Individual and Systemic Factors Impacting Interagency Collaboration. Subst Use Addctn J. 2025 Jul; 46(3):531-540.
    View in: PubMed
    Score: 0.017
  23. Carreiro S, Ramanand P, Akram W, Stapp J, Chapman B, Smelson D, Indic P. Developing a Wearable Sensor-Based Digital Biomarker of Opioid Dependence. Anesth Analg. 2025 Aug 01; 141(2):393-402.
    View in: PubMed
    Score: 0.017
  24. Bowdring MA, Macia KS, Shaffer PM, Smelson D, Blonigen DM. Criminogenic Needs and?Legal Problem Severity Among Legal System Involved Veterans. Mil Med. 2024 Jul 03; 189(7-8):e1544-e1551.
    View in: PubMed
    Score: 0.017
  25. Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004 Jul; 27(1):45-9.
    View in: PubMed
    Score: 0.017
  26. Carreiro S, Ramanand P, Taylor M, Leach R, Stapp J, Sherestha S, Smelson D, Indic P. Evaluation of a digital tool for detecting stress and craving in SUD recovery: An observational trial of accuracy and engagement. Drug Alcohol Depend. 2024 Aug 01; 261:111353.
    View in: PubMed
    Score: 0.017
  27. Swong S, Nicholson A, Smelson D, Rogers ES, El-Shahawy O, Sherman SE. The effectiveness of a telephone smoking cessation program in mental health clinic patients by level of mental well-being and functioning: a secondary data analysis of a randomized clinical trial. BMC Public Health. 2023 11 07; 23(1):2190.
    View in: PubMed
    Score: 0.016
  28. Suzuki J, Martin B, Loguidice F, Smelson D, Liebschutz JM, Schnipper JL, Weiss RD. A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial. J Addict Med. 2023 Sep-Oct 01; 17(5):604-607.
    View in: PubMed
    Score: 0.015
  29. Smelson DA, Losonczy MF, Kilker C, Starosta A, Kind J, Williams J, Ziedonis D. An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. Psychiatr Serv. 2002 Dec; 53(12):1612-6.
    View in: PubMed
    Score: 0.015
  30. Hayes D, Henderson C, Bakolis I, Lawrence V, Elliott RA, Ronaldson A, Richards G, Repper J, Bates P, Brewin J, Meddings S, Winship G, Bishop S, Emsley R, Elton D, McNaughton R, Whitley R, Smelson D, Stepanian K, McPhilbin M, Dunnett D, Hunter-Brown H, Yeo C, Jebara T, Slade M. Recovery Colleges Characterisation and Testing in England (RECOLLECT): rationale and protocol. BMC Psychiatry. 2022 09 24; 22(1):627.
    View in: PubMed
    Score: 0.015
  31. Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002 Sep; 47(7):671-5.
    View in: PubMed
    Score: 0.015
  32. Smelson DA, Roy A, Roy M, Tershakovec D, Engelhart C, Losonczy MF. Electroretinogram and cue-elicited craving in withdrawn cocaine-dependent patients: a replication. Am J Drug Alcohol Abuse. 2001 May; 27(2):391-7.
    View in: PubMed
    Score: 0.013
  33. Jasuja GK, Bettano A, Smelson D, Bernson D, Rose AJ, Byrne T, Berlowitz DR, McCullough MB, Miller DR. Homelessness and Veteran Status in Relation to Nonfatal and Fatal Opioid Overdose in Massachusetts. Med Care. 2021 04 01; 59(Suppl 2):S165-S169.
    View in: PubMed
    Score: 0.013
  34. Morse E, Binswanger IA, Taylor E, Gray C, Stimmel M, Timko C, Harris AHS, Smelson D, Finlay AK. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. J Subst Abuse Treat. 2021 10; 129:108353.
    View in: PubMed
    Score: 0.013
  35. Blonigen DM, Shaffer PM, Smith JS, Cucciare MA, Timko C, Smelson D, Blue-Howells J, Clark S, Rosenthal J. Recidivism Treatment for Justice-Involved Veterans: Evaluating Adoption and Sustainment of Moral Reconation Therapy in the US Veterans Health Administration. Adm Policy Ment Health. 2021 11; 48(6):992-1005.
    View in: PubMed
    Score: 0.013
  36. Byrne T, Baggett T, Land T, Bernson D, Hood ME, Kennedy-Perez C, Monterrey R, Smelson D, Dones M, Bharel M. A classification model of homelessness using integrated administrative data: Implications for targeting interventions to improve the housing status, health and well-being of a highly vulnerable population. PLoS One. 2020; 15(8):e0237905.
    View in: PubMed
    Score: 0.013
  37. Carreiro S, Chintha KK, Shrestha S, Chapman B, Smelson D, Indic P. Wearable sensor-based detection of stress and craving in patients during treatment for substance use disorder: A mixed methods pilot study. Drug Alcohol Depend. 2020 04 01; 209:107929.
    View in: PubMed
    Score: 0.012
  38. Midboe AM, Byrne T, Smelson D, Jasuja G, McInnes K, Troszak LK. The Opioid Epidemic In Veterans Who Were Homeless Or Unstably Housed. Health Aff (Millwood). 2019 08; 38(8):1289-1297.
    View in: PubMed
    Score: 0.012
  39. Smelson DA, Roy A, Santana S, Engelhart C. Neuropsychological deficits in withdrawn cocaine-dependent males. Am J Drug Alcohol Abuse. 1999 May; 25(2):377-81.
    View in: PubMed
    Score: 0.012
  40. Smelson DA, McGee-Caulfield E, Bergstein P, Engelhart C. Initial validation of the Voris Cocaine Craving Scale: a preliminary report. J Clin Psychol. 1999 Jan; 55(1):135-9.
    View in: PubMed
    Score: 0.011
  41. Smelson DA, Roy M, Roy A, Santana S. Electroretinogram in withdrawn cocaine-dependent subjects. Relationship to cue-elicited craving. Br J Psychiatry. 1998 Jun; 172:537-9.
    View in: PubMed
    Score: 0.011
  42. Roy A, Roy M, Smelson DA. Risperidone, ERG and cocaine craving. Am J Addict. 1998; 7(1):90.
    View in: PubMed
    Score: 0.011
  43. DiGirolamo GJ, Gonzalez G, Smelson D, Guevremont N, Andre MI, Patnaik PO, Zaniewski ZR. Increased Depression and Anxiety Symptoms are Associated with More Breakdowns in Cognitive Control to Cocaine Cues in Veterans with Cocaine Use Disorder. J Dual Diagn. 2017 Oct-Dec; 13(4):298-304.
    View in: PubMed
    Score: 0.011
  44. Desai P, Roy M, Roy A, Brown S, Smelson D. Impaired color vision in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Aug; 54(8):696-9.
    View in: PubMed
    Score: 0.010
  45. Blonigen DM, Rodriguez AL, Manfredi L, Nevedal A, Rosenthal J, McGuire JF, Smelson D, Timko C. Cognitive-behavioral treatments for criminogenic thinking: Barriers and facilitators to implementation within the Veterans Health Administration. Psychol Serv. 2018 Feb; 15(1):87-97.
    View in: PubMed
    Score: 0.010
  46. Smelson DA, Roy A, Roy M. Risperidone and neuropsychological test performance in cocaine-withdrawn patients. Can J Psychiatry. 1997 May; 42(4):431.
    View in: PubMed
    Score: 0.010
  47. Roy M, Roy A, Williams J, Weinberger L, Smelson D. Reduced blue cone electroretinogram in cocaine-withdrawn patients. Arch Gen Psychiatry. 1997 Feb; 54(2):153-6.
    View in: PubMed
    Score: 0.010
  48. Krebs P, Rogers E, Smelson D, Fu S, Wang B, Sherman S. Relationship between tobacco cessation and mental health outcomes in a tobacco cessation trial. J Health Psychol. 2018 07; 23(8):1119-1128.
    View in: PubMed
    Score: 0.010
  49. Okunna NC, Rodriguez-Monguio R, Smelson DA, Poudel KC, Volberg R. Gambling involvement indicative of underlying behavioral and mental health disorders. Am J Addict. 2016 Mar; 25(2):160-72.
    View in: PubMed
    Score: 0.009
  50. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend. 2016 Mar 01; 160:222-6.
    View in: PubMed
    Score: 0.009
  51. Rogers ES, Smelson DA, Gillespie CC, Elbel B, Poole S, Hagedorn HJ, Kalman D, Krebs P, Fang Y, Wang B, Sherman SE. Telephone Smoking-Cessation Counseling for Smokers in Mental Health Clinics: A Patient-Randomized Controlled Trial. Am J Prev Med. 2016 Apr; 50(4):518-527.
    View in: PubMed
    Score: 0.009
  52. Carreiro S, Fang H, Zhang J, Wittbold K, Weng S, Mullins R, Smelson D, Boyer EW. iMStrong: Deployment of a Biosensor System to Detect Cocaine Use. J Med Syst. 2015 Dec; 39(12):186.
    View in: PubMed
    Score: 0.009
  53. Gonzalez G, DiGirolamo G, Romero-Gonzalez M, Smelson D, Ziedonis D, Kolodziej M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015 Nov 01; 156:243-253.
    View in: PubMed
    Score: 0.009
  54. Finlay AK, Binswanger IA, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Blodgett JC, Harris AH, Asch SM, Frayne S. Sex differences in mental health and substance use disorders and treatment entry among justice-involved Veterans in the Veterans Health Administration. Med Care. 2015 Apr; 53(4 Suppl 1):S105-11.
    View in: PubMed
    Score: 0.009
  55. DiGirolamo GJ, Smelson D, Guevremont N. Cue-induced craving in patients with cocaine use disorder predicts cognitive control deficits toward cocaine cues. Addict Behav. 2015 Aug; 47:86-90.
    View in: PubMed
    Score: 0.009
  56. Carreiro S, Smelson D, Ranney M, Horvath KJ, Picard RW, Boudreaux ED, Hayes R, Boyer EW. Real-time mobile detection of drug use with wearable biosensors: a pilot study. J Med Toxicol. 2015 Mar; 11(1):73-9.
    View in: PubMed
    Score: 0.009
  57. Rogers E, Fernandez S, Gillespie C, Smelson D, Hagedorn HJ, Elbel B, Kalman D, Axtmayer A, Kurowski K, Sherman SE. Telephone care coordination for smokers in VA mental health clinics: protocol for a hybrid type-2 effectiveness-implementation trial. Addict Sci Clin Pract. 2013 Mar 15; 8:7.
    View in: PubMed
    Score: 0.008
  58. Boyer EW, Fletcher R, Fay RJ, Smelson D, Ziedonis D, Picard RW. Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project. J Med Toxicol. 2012 Mar; 8(1):5-9.
    View in: PubMed
    Score: 0.007
  59. Ellison ML, Mueller L, Smelson D, Corrigan PW, Torres Stone RA, Bokhour BG, Najavits LM, Vessella JM, Drebing C. Supporting the education goals of post-9/11 veterans with self-reported PTSD symptoms: a needs assessment. Psychiatr Rehabil J. 2012; 35(3):209-17.
    View in: PubMed
    Score: 0.007
  60. Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow FC. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull. 2011 Jul; 37(4):727-36.
    View in: PubMed
    Score: 0.006
  61. Banerjea R, Pogach LM, Smelson D, Sambamoorthi U. Mental illness and substance use disorders among women veterans with diabetes. Womens Health Issues. 2009 Nov-Dec; 19(6):446-56.
    View in: PubMed
    Score: 0.006
  62. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Chronic illness with complexities: mental illness and substance use among Veteran clinic users with diabetes. Am J Drug Alcohol Abuse. 2007; 33(6):807-21.
    View in: PubMed
    Score: 0.005
  63. Sussner BD, Smelson DA, Rodrigues S, Kline A, Losonczy M, Ziedonis D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend. 2006 Jul 27; 83(3):233-7.
    View in: PubMed
    Score: 0.005
  64. Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA. 2003 Nov 26; 290(20):2693-702.
    View in: PubMed
    Score: 0.004
  65. Carol G, Smelson DA, Losonczy MF, Ziedonis D. Alcohol & drug abuse: a preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatr Serv. 2001 Aug; 52(8):1029-31.
    View in: PubMed
    Score: 0.003
  66. Roy M, Roy A, Smelson D, Brown S, Weinberger L. Reduced blue cone electroretinogram in withdrawn cocaine dependent patients: a replication. Biol Psychiatry. 1997 Oct 01; 42(7):631-3.
    View in: PubMed
    Score: 0.003
  67. Roy M, Smelson D, Roy A. Longitudinal study of blue cone retinal function in cocaine-withdrawn patients. Biol Psychiatry. 1997 Jan 15; 41(2):252-3.
    View in: PubMed
    Score: 0.002
  68. Roy M, Smelson DA, Roy A. Abnormal electroretinogram in cocaine-dependent patients. Relationship to craving. Br J Psychiatry. 1996 Apr; 168(4):507-11.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.